- $266.27bn
- $263.30bn
- €31.21bn
- 95
- 16
- 73
- 63
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 27,553 | 27,338 | 27,842 | 29,520 | 31,207 |
Cost of Revenue | |||||
Gross Profit | 19,515 | 19,705 | 20,118 | 21,571 | 22,603 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 23,080 | 20,715 | 23,186 | 23,430 | 25,420 |
Operating Profit | 4,473 | 6,623 | 4,656 | 6,090 | 5,787 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 4,596 | 7,220 | 6,847 | 4,513 | 5,341 |
Provision for Income Taxes | |||||
Net Income After Taxes | 3,370 | 5,282 | 5,376 | 3,067 | 3,600 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 3,320 | 5,144 | 5,255 | 2,284 | 6,138 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 3,321 | 5,145 | 5,256 | 2,284 | 6,139 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.87 | 4.75 | 4.92 | 3.37 | 3.61 |
Dividends per Share | |||||
Special Dividends per Share |